BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23185961)

  • 1. Spontaneous regression of chronic lymphocytic leukemia to a monoclonal B-lymphocytosis or to a normal phenotype.
    Nakhla PS; Butera JN; Treaba DO; Castillo JJ; Quesenberry PJ
    Leuk Lymphoma; 2013 Aug; 54(8):1647-51. PubMed ID: 23185961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphoma-like monoclonal B cell lymphocytosis in a patient population: biology, natural evolution, and differences from CLL-like clones.
    Vander Meeren S; Heyrman B; Renmans W; Bakkus M; Maes B; De Raeve H; Schots R; Jochmans K
    Ann Hematol; 2018 Jul; 97(7):1219-1227. PubMed ID: 29492600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal B-cell lymphocytosis in the bone marrow: revisiting the criteria for chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Ryder CB; Oduro KA; Moore EM
    Hum Pathol; 2022 Jul; 125():108-116. PubMed ID: 35472399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief report: natural history of individuals with clinically recognized monoclonal B-cell lymphocytosis compared with patients with Rai 0 chronic lymphocytic leukemia.
    Shanafelt TD; Kay NE; Rabe KG; Call TG; Zent CS; Maddocks K; Jenkins G; Jelinek DF; Morice WG; Boysen J; Schwager S; Bowen D; Slager SL; Hanson CA
    J Clin Oncol; 2009 Aug; 27(24):3959-63. PubMed ID: 19620484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous presentation of chronic lymphocytic leukemia as unique extramedullar involvement in a patient with normal peripheral blood lymphocyte count (monoclonal B-cell lymphocytosis).
    Tapia G; Mate JL; Fuente MJ; Navarro JT; Fernández-Figueras MT; Juncà J; Ferrándiz C; Ariza A
    J Cutan Pathol; 2013 Aug; 40(8):740-4. PubMed ID: 23639136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
    Rawstron AC; Bennett FL; O'Connor SJ; Kwok M; Fenton JA; Plummer M; de Tute R; Owen RG; Richards SJ; Jack AS; Hillmen P
    N Engl J Med; 2008 Aug; 359(6):575-83. PubMed ID: 18687638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal B-lymphocytosis: demographics, nature and subclassification in 414 community patients.
    Mulligan CS; Thomas ME; Mulligan SP
    Leuk Lymphoma; 2011 Dec; 52(12):2293-8. PubMed ID: 21756037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telomere length analysis in monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia Binet A.
    Furtado FM; Scheucher PS; Santana BA; Scatena NF; Calado RT; Rego EM; Matos DM; Falcão RP
    Braz J Med Biol Res; 2017 Apr; 50(5):e6019. PubMed ID: 28423121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What does it mean I have a monoclonal B-cell lymphocytosis?: Recent insights and new challenges.
    Scarfò L; Ghia P
    Semin Oncol; 2016 Apr; 43(2):201-8. PubMed ID: 27040697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of prognostic factors in asymptomatic patients with B-cell chronic lymphocytic leukemia-like lymphocytosis: the cut-off of 11 × 10(9)/L monoclonal lymphocytes better identifies subgroups with different outcomes.
    Oliveira AC; Fernández de Sevilla A; Domingo A; De La Banda E; Domingo-Domènech E; Mercadal S; Ruiz-Xivillé N; Alonso E; Encuentra M; González-Barca E
    Ann Hematol; 2015 Apr; 94(4):627-32. PubMed ID: 25471173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronic lymphocytic leukaemia presenting with specific cutaneous infiltrates in the absence of lymphocytosis: Two cases].
    Vonarx M; Carpentier O; Cazin B; Bouchindhomme B; Delaporte E
    Ann Dermatol Venereol; 2012 Oct; 139(10):641-6. PubMed ID: 23122378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal B lymphocytosis versus chronic lymphocytic leukemia: factors affecting implementation of an absolute threshold.
    Rollins-Raval MA; Fisher J; Craig FE
    Cytometry B Clin Cytom; 2013 May; 84(3):149-56. PubMed ID: 23475845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of monoclonal B-cell lymphocytosis.
    Mowery YM; Lanasa MC
    Cancer Control; 2012 Jan; 19(1):8-17. PubMed ID: 22143058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical progression and outcome of patients with monoclonal B-cell lymphocytosis.
    Fung SS; Hillier KL; Leger CS; Sandhu I; Vickars LM; Galbraith PF; Li CH; Leitch HA
    Leuk Lymphoma; 2007 Jun; 48(6):1087-91. PubMed ID: 17577771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More on spontaneous regression of chronic lymphocytic leukemia: two new cases and potential role of lamivudine in a further patient with advanced disease and hepatitis B virus infection.
    D'Arena G; Guariglia R; Pietrantuono G; Villani O; Martorelli MC; Mansueto G; Criscuolo C; Pierri T; Musto C; Musto P
    Leuk Lymphoma; 2014 Aug; 55(8):1955-7. PubMed ID: 24152050
    [No Abstract]   [Full Text] [Related]  

  • 16. General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL.
    Fazi C; Scarfò L; Pecciarini L; Cottini F; Dagklis A; Janus A; Talarico A; Scielzo C; Sala C; Toniolo D; Caligaris-Cappio F; Ghia P
    Blood; 2011 Dec; 118(25):6618-25. PubMed ID: 21876118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal B-cell lymphocytosis: a reappraisal of its clinical implications.
    Molica S; Mauro FR; Molica M; Del Giudice I; Foà R
    Leuk Lymphoma; 2012 Sep; 53(9):1660-5. PubMed ID: 22335530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal B-cell lymphocytosis.
    Maitre E; Troussard X
    Best Pract Res Clin Haematol; 2019 Sep; 32(3):229-238. PubMed ID: 31585623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines.
    Call TG; Norman AD; Hanson CA; Achenbach SJ; Kay NE; Zent CS; Ding W; Cerhan JR; Rabe KG; Vachon CM; Hallberg EJ; Shanafelt TD; Slager SL
    Cancer; 2014 Jul; 120(13):2000-5. PubMed ID: 24711224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation, progression, and outcome of patients with clonal B-cell counts of less than 5 × 10(9)/l, 5 to 10 × 10(9)/l, and more than 10 × 10(9)/l and chronic lymphocytic leukemia immunophenotype.
    Foster AE; Nguyen TT; Al-Hammadi N; Frater JL; Hassan A; Kreisel F
    Am J Clin Pathol; 2015 Jan; 143(1):70-7. PubMed ID: 25511144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.